Your Client Rank:
Loading...
99
Updated 07-Jul-2020
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Vertex | 10.8% | 0.3% | -4.7% | -7.0% | 5.9% | 1.7% | 15.1% | 14.4% |
| Astra | 9.3% | 0.5% | -4.8% | -4.3% | 9.6% | 0.0% | 18.1% | 18.2% |
| Daiichi | 9.3% | 2.7% | -2.0% | -5.1% | 24.6% | -0.5% | 35.9% | 36.4% |
| Mylan | 8.9% | 2.7% | 0.6% | -1.5% | 6.6% | 0.0% | 18.8% | -2.0% |
| Regeneron | 7.7% | -0.3% | -2.3% | -3.0% | 0.5% | 2.4% | 8.5% | 7.7% |
| Alexion | 7.3% | 0.0% | -2.5% | 0.0% | -1.9% | -0.4% | 6.9% | 8.1% |
| Novo | 6.6% | 0.0% | -1.2% | 0.8% | -0.1% | 0.1% | 7.5% | 9.4% |
| Lilly | 6.4% | 0.3% | -3.4% | -3.4% | 4.1% | 0.2% | 11.4% | 11.8% |
| Merck KG | 5.3% | 0.6% | -1.9% | -2.0% | 6.4% | 0.8% | 8.6% | 9.6% |
| Eisai | 4.8% | -0.1% | -1.5% | -4.8% | 10.5% | 0.9% | 14.8% | 14.1% |
| Chugai | 4.7% | 1.0% | 0.2% | -0.2% | 1.6% | -0.3% | 6.7% | 6.8% |
| Merck | 4.3% | 0.7% | -1.8% | -2.0% | 3.1% | 0.3% | 7.8% | 9.2% |
| Roche | 4.2% | 0.3% | -0.9% | -0.9% | 1.7% | 0.4% | 6.6% | 6.7% |
| JnJ | 4.1% | 0.6% | -0.8% | -0.8% | 1.9% | 0.5% | 5.8% | 7.0% |
| Astellas | 3.9% | -0.2% | -1.2% | -2.9% | 3.7% | 0.3% | 8.0% | 14.3% |
| AbbVie | 3.9% | -0.5% | -0.5% | -1.1% | -0.1% | 4.2% | 4.4% | 3.7% |
| Glaxo | 3.8% | 0.4% | -1.5% | 0.8% | 2.3% | 2.6% | 6.3% | 6.1% |
| Lundbeck | 3.8% | 1.2% | -4.5% | -7.9% | 23.1% | 1.6% | 12.4% | 12.6% |
| Sanofi | 3.3% | 0.6% | -2.5% | -2.7% | 4.7% | 0.4% | 6.4% | 7.0% |
| Pfizer | 3.2% | 0.5% | -2.7% | -2.3% | 2.7% | 0.2% | 6.5% | 7.5% |
| Amgen | 3.2% | -0.2% | -1.2% | -0.8% | 0.4% | 0.9% | 5.0% | 7.1% |
| Novartis | 3.1% | 0.2% | -0.5% | -1.0% | 2.3% | -0.1% | 5.7% | 6.6% |
| Bristol | 3.0% | -1.0% | -2.3% | -2.4% | 1.8% | 0.0% | 5.8% | 7.4% |
| Bayer | 1.7% | -0.3% | -1.9% | -0.7% | 4.6% | -0.1% | 5.4% | 5.8% |
| Takeda | 1.2% | 0.2% | -2.8% | -1.2% | 17.0% | -17.5% | 44.2% | 44.2% |
| Teva | 1.0% | 0.9% | -0.4% | -0.6% | 1.5% | 0.1% | 3.9% | 3.8% |
| UCB | 0.3% | -0.3% | 1.6% | -1.1% | 2.6% | 2.5% | 2.5% | 4.3% |
| Gilead | 0.3% | 0.1% | -0.7% | -0.2% | 0.9% | 0.2% | 1.5% | 2.8% |
| Biogen | -0.3% | -0.5% | 1.7% | 1.4% | -1.6% | 0.4% | -2.5% | 0.1% |
| Shionogi | | | | | | | | |
| EU Major | 4.1% | 0.4% | -1.8% | -1.1% | 3.3% | 0.6% | 7.4% | 7.9% |
| Other EU | 4.2% | 0.4% | -1.6% | -3.1% | 6.7% | 2.0% | 7.9% | 8.2% |
| US Major | 4.0% | 0.1% | -1.6% | -1.9% | 1.9% | 0.8% | 6.4% | 7.5% |
| US Big Biotech | 3.2% | 0.0% | -1.3% | -0.9% | 0.4% | 0.4% | 4.4% | 5.8% |
| Other US | 4.5% | 1.8% | 0.1% | -1.5% | 4.6% | 0.2% | 11.7% | 0.2% |
| Japanese | 3.7% | 0.5% | -1.8% | -2.3% | 11.1% | -5.5% | 20.4% | 21.6% |
